3
Disclosures
Feb 2, 2026 — Mar 23, 2026
Date Range
GROWTH
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 23 Equity Issuance Chiome Bioscience: Seals Deal With Astellas Pharma for Antibody License PDF
Mar 19 Other Chiome Bioscience: Reports Massive Exercise of Warrant Options in March PDF
Mar 17 Other Chiome Bioscience: Secures European Patent for Cancer Treatment Antibody PDF

Disclosure Types

Other: 2 Equity Issuance: 1